Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags), Consumer (Adults, Children), End User (Healthcare Facilities, Pharmacies & Compounding Service Providers) – Global Forecast to 2031

The Parenteral Nutrition Bags Market was valued at $0.76  billion in 2023. This market is expected to reach $1.25  billion by 2031, from an estimated $0.8  billion in 2024, at a CAGR of 6.6% during the forecast period 2024-2031.

Parenteral Nutrition Bags Market Size & Forecast

Parenteral nutrition bags are empty containers utilized to compound and store parenteral nutritional solutions prior to and during intravascular administration to a patient. Parenteral nutrition bags are used by compounding pharmacies (both independent and hospital-associated) and compounding service provider companies for compounding and storing parenteral nutritional solutions.

The growth of the parenteral nutrition bags market is driven by the growing prevalence of chronic and infectious diseases, the rising global prevalence of malnutrition, the large number of premature births, and the increasing incidence of metabolic disorders. Furthermore, the growing adoption of home healthcare, the rising global geriatric population, and emerging economies are expected to generate growth opportunities for the stakeholders in this market. However, concerns over the infection risks associated with parenteral nutrition restrain the growth of this market. The lack of awareness regarding parenteral nutrition in developing countries is a major challenge impacting the growth of the parenteral nutrition bags market.

Growing Preference for Home Healthcare

The emergence of home healthcare has enabled patients to receive hospital-like care in their homes. Home healthcare has also proved to be a cheaper, safer, and more effective alternative to traditional hospital care, mainly for patients at risk of complications from inpatient care and hospital-acquired infections. The use of parenteral nutrition bags makes it easy for patients to receive the required nourishment and nutrition in the comfort of their homes and is cost-effective as well. These advantages of home care have led many countries, such as the U.S., the U.K., Canada, Australia, and Israel, to implement government policies promoting homecare health services. For instance, every regional and metropolitan hospital in Victoria, Australia, has a hospital-athome program, with nearly 6% of all hospital bed days provided through the program.

As per the Johns Hopkins Model, the cost of at-home care was 32% less than hospital care (USD 5,081 VS. USD 7,480), and the length of stay for patients was also reduced by nearly one-third (4.9 days VS. 32 days). Additionally, the home care setting was found to be more convenient for family members and patients than usual hospital care. Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) are used as indicators of people’s ability to care for themselves independently. The elderly population (aged 60 years or over) and older adults (aged 45 to 59 years) are more likely to have ADL and IADL-related difficulties. For instance, according to India’s Ministry of Health and Family Welfare (MoHFW), in 2020, about 9% of older adults had at least 1 ADL limitation, and 36% had at least one IADL limitation.

Homecare services provide a combination of assistance with ADL and medical care at home. Assistance with activities such as bathing, brushing, walking, changing positions, and social interactions, along with monitoring of vitals such as blood pressure, blood sugar levels, temperature, oxygen saturation, intravenous or intramuscular injections, and nutrition management through parenteral nutrition, are some of the common services provided at home. Additionally, the reduced need for rehospitalization, expensive and unnecessary testing, and shorter treatment times are some of the other benefits driving the adoption of home healthcare.

Large Number of Premature Births and Rising Prevalence of Chronic Diseases in Geriatric Population

The energy and nutrient requirements of pre-term babies and infants cannot be safely fulfilled via the enteral route immediately after birth. Hence, parenteral nutrition is considered a part of standard newborn care. According to the World Health Organization (WHO), in 2020, approximately 13.4 million (equivalent to approximately 1 in 10) babies were born pre-term (before the completion of 37 weeks of gestation) globally. Parenteral nutrition is an important part of newborn care. It provides optimal nutrition, reduces postnatal growth failure, minimizes the risk of excessive nutrient intake and electrolyte abnormalities, and optimizes vitamin, trace element, and mineral intake. Therefore, the rise in pre-term births is boosting the demand for parenteral nutrition, including nutrition bags, driving the growth of the market.

Additionally, the rising prevalence of chronic diseases due to growth in the global geriatric population is also driving the parenteral nutrition bags market. As per United Nations data, the percentage of the population aged 65 years or over is increasing globally. In 2022, about 9.7% of the world population was aged 65 years or over, which is expected to increase to 11.7% in 2030 and to 16.4% in 2050. The rising geriatric population is driving an increase in the number of chronic disease cases, leading to increased hospital admissions. The geriatric population has low immunity and adaptability. As a result, their nutritional requirements cannot be fulfilled by oral medicines/supplements. Parenteral nutrition provides them with the required nourishment. Thus, the adoption of parenteral nutrition bags is increasing globally due to the rising global geriatric population.

Click here to: Get Free Sample Pages of this Report

Key Findings of the Parenteral Nutrition Bags Market Study:

The Single-Chamber Parenteral Nutrition Bags Segment is Expected to Account for the Largest Share of the Market in 2024

Among chamber types, in 2024, the single-chamber parenteral nutrition bags segment is expected to account for the largest share of the market. Single-chamber parenteral nutrition bags are designed to compound and store a comprehensive blend of nutritional solutions, including electrolytes, amino acids, lipids, vitamins, carbohydrates, and trace elements within a single compartment for parenteral administration. The large share of the segment is attributed to factors such as the high prescription rate, wide availability of single-chamber bags, and their ease of use, handling, transportation, and disposal.

The Adults Segment is Expected to Account for the Largest Share of the Market in 2024

Among consumers, in 2024, the adults segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as the increasing prevalence of gastrointestinal disorders, rising number of surgeries, rising rate of hospitalization, and growth of the geriatric population. For instance, according to the research conducted by Crohn’s & Colitis UK (U.K.), one in every 123 people have Crohn’s disease or ulcerative colitis in the U.K. In such cases, as parenteral nutrition therapy bypasses the gastrointestinal tract, it is used for providing nutrition to patients who have Crohn’s disease, Inflammatory Bowel Disease (IBD), and gastrointestinal bleeding, among other conditions, supporting the growth of the market.

The Healthcare Facilities Segment is Expected to Account for the Largest Share of the Market in 2024

Among end users, in 2024, the healthcare facilities segment is expected to account for the largest share of the market. The large share of the segment is attributed to factors such as the large number of patients visiting hospitals and clinics for disease diagnosis and treatment, growing disease burden, an associated rise in the rates of prescription for parenteral nutrition, and the presence of advanced compounding equipment in the hospital associated compounding pharmacies. There are certain diseases, such as cancer and gastrointestinal disorders, where the patient cannot be provided with nutrition orally; hence, parenteral nutrition is used. This increases the demand for parenteral nutrition bags. For instance, according to GLOBOCAN, the incidence of stomach cancer is expected to increase by 82.3% in Asia by 2045 and 25.7% by 2045 in Europe.

North America: Largest Regional Market

Among geographies, in 2024, North America is expected to account for the largest share of the market. The large share of the segment is primarily due to the increasing prevalence of chronic diseases, the presence of key market players, the established healthcare system, and the rising geriatric population. For instance, according to projections from the United Nations, the population of individuals aged 60 years and older in North America is anticipated to reach 123 million by 2050, an increase from 79 million in 2017. This demographic group is particularly susceptible to multiple chronic diseases and may struggle to meet their nutritional requirements through conventional means, such as eating or enteral nutrition. Therefore, parenteral nutrition bags can serve as a valuable solution for delivering essential nutrition intravenously.

Parenteral Nutrition Bags Market: Competitive Analysis

The key players profiled in the parenteral nutrition bags market report are B. Braun SE (Germany), Baxter International, Inc. (U.S.), Fresenius Kabi AG (Germany), GVS S,p.A. (Italy), Grifols, S.A. (Spain), Technolflex (France), RENOLIT Healthcare (Germany), Valmed s.r.l (Italy), HEMEDIS GmbH  (Germany), INFRA Srl (Italy), Beijing L&Z Medical Technology Development Co., Ltd.(China), Boen Healthcare Co., Ltd. (China),  AdvaCare Pharma  (U.S.), and Diffuplast S.r.l. (Italy).

The report includes a competitive landscape based on an extensive assessment of the market based on chamber type, consumer, and end user. The report also provides insights into the presence of major market players and their key growth strategies in the last three to four years.

Parenteral Nutrition Bags Market Report Summary

Key questions answered in the report: